Abstract:OBJECTIVE:To investigate the anti-tumor effects of human single chain interleukin-12 (hscIL-12).METHOD:pcDNA/hscIL-12 recombinant was transfected into human hepatic carcinoma cells (7721 cells) by lipofectin method. The 7721/hscIL-12 cells which secrete hscIL-12 stably, were obtained via G418 selection, and in vitro the influence of hscIL-12 gene transduction on the growth of tumor cells was evaluated by cell cycle analysis. In vivo, genetically engineered 7721 cells (7721/hscIL-12, 7721/pcDNA) and parental cells were implanted into BALB/c nude mice, respectively. 7721/pcDNA and 7721/hscIL-12 groups were divided into two sub-groups on day 8: one was administered with hPBL twice, 6 days at interval; the other was given equal volume of PBS. Mice were sacrificed on day 26, and spleens and tumors were taken out for histologic assay.RESULTS:hscIL-12 produced stably by 7721/hscIL-12 cells had bioactivity, and it was proved by Western blot, immunocytochemistry, and in situ hybridization. In vitro, compared with 7721 and 7721/pcDNA, the 7721/hscIL-12 grew much more slowly. FACS assay showed apparent G1 arrest of 7721/hscIL-12 cells. In animal experiment, on day 8 after inoculation, the tumors of 7721 and 7721/pcDNA group were up to 5 approximately 7 mm, while those of 7721/hscIL-12 group were 2 approximately 4 mm. When treated with hPBL, the tumor of 7721/hscIL-12 group disappeared completely. Histologically, the tumors from 7721/hscIL-12 without hPBL treatment had numerous lymphocyte infiltration, the tumor cells displayed depression looking, atrophy, focal necrosis and apoptosis, whereas the tumors of 7721 and 7721/pcDNA groups grew thrivingly.CONCLUSION:hscIL-12 transduced 7721 cells could induced significant antitumor immune response which resulted in tumor regression totally when the hPBL was inoculated, and also hscIL-12 has certain effects on mice immune system. These findings suggest that hscIL-12 and hscIL-12 gene therapy might have promising prospects in clinical application.

Establishment of Stably Transformed BmN Cells Expressing Human Interlukin-28A and in vitro Anti-tumor Activity of the Expressed Product

Expression of Mouse Anti-human CD28 Single Chain Antibody Using Bombyx mori HyNPV Expression System

Expression of recombinant BC047440 protein and its effects on proliferation of HepG2 cells in vitro

Intratumoral IL-28B Gene Delivery Elicits Antitumor Effects by Remodeling of the Tumor Microenvironment in H22-Bearing Mice

Enhanced Anti-Tumor (Anti-Proliferation) Activity of Recombinant Human Interleukin-29 (IL-29) Mutants Using Site-Directed Mutagenesis Method

Expression of Human Endostatin in Larvae of Silkworm (bombyx Mori) and in Vitro Activity Assays.

[Site-directed mutagenesis of human IL-29 and antineoplastic activity of the recombinant human IL-29 variant]

Expression and Activity Determination of Human Angiostatin (K1-3) in Culture Cells and Larvae of Silkworm.

Study on the Expression and Immune Enhancement of IL-18-GPI Fused Protein

[Construction and Expression of Eukaryotic Expression Plasmid Pcdna3.1/hil-18].

[Expression of Hgm-Csf in Transformed Silkworm BmN Cells Mediated by Non-Transposon Vector].

Antitumor Effects Of Interleukin-18 Gene-Modified Hepatocyte Cell Line On Implanted Liver Carcinoma

Expression of hGM-CSF in Stably Transformed BmN Cells of Bombyx mori

Construction and expression of eukaryotic plasmids containing human IL-27 protein subunits

[Expression and identification of recombinant mouse gene B7-H4].

Prokaryotic Expression, Purification and Bioactivity of Recombinant Mouse Interleukin 17f/his Fusion Protein

THE INFLUENCE OF HUMAN SINGLE CHAIN INTELEUKIN-12 GENE TRANSDUCTION ON THE BIOLOGICAL BEHAVIOR OF HEPATOMA 7721 CELLS

Expression, Purification, and Polyethylene Glycol Site-Specific Modification of Recombinant Human Interleukin 24 in Escherichia coli

Long-term anti-tumor effects of microencapsulated murine interleukins-12 engineered cells

Construction and its Antitumor Efficiency of Murine Interleukin 21 Tumor Vaccine

Study on Interleukin-18 Gene Transfer into Human Breast Cancer Cells to Prevent Tumorigenicity